SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Catalyst Biosciences Q3 EPS $(1.06) Down From $(0.64) YoY

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(1.06) per share. This is a 65.63 percent decrease over losses of $(0.64) per share from the same period last year.

Benzinga · -

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(1.06) per share. This is a 65.63 percent decrease over losses of $(0.64) per share from the same period last year.